Vitaliy Sviripa

Vitaliy Sviripa

University of Kentucky

H-index: 17

North America-United States

About Vitaliy Sviripa

Vitaliy Sviripa, With an exceptional h-index of 17 and a recent h-index of 14 (since 2020), a distinguished researcher at University of Kentucky, specializes in the field of Organic Chemistry, Medicinal Chemistry, Biochemistry, Drug Development.

His recent articles reflect a diverse array of research interests and contributions to the field:

Substituted N-Benzhydrylacetamide Inhibitors of Jamanji Domain Histone Demethylases for the Treatment of Cancer

Crizotinib induces Par-4 secretion from normal cells and GRP78 expression on the cancer cell surface for selective tumor growth inhibition

Novel Superebastine Against Therapy Resistant Prostate Cancer

Coumarin-modified androgens for the treatment of prostate cancer

Amino-substituted 3-Aryl-and 3-heteroarylquinolines as potential antileishmanial agents

Chemoselective synthesis of 3-trifluoromethylpyrazole-deoxybenzoin hybrids

Developing Quinoline-based Secretagogues for Prostate Apoptosis Response-4 Protein (Par-4) as Potential Antineoplastic Agents

Potent Synergistic Effect on C-Myc–Driven Colorectal Cancers Using a Novel Indole-Substituted Quinoline with a Plk1 Inhibitor

Vitaliy Sviripa Information

University

Position

Research Assistant Professor

Citations(all)

887

Citations(since 2020)

460

Cited By

623

hIndex(all)

17

hIndex(since 2020)

14

i10Index(all)

26

i10Index(since 2020)

18

Email

University Profile Page

University of Kentucky

Google Scholar

View Google Scholar Profile

Vitaliy Sviripa Skills & Research Interests

Organic Chemistry

Medicinal Chemistry

Biochemistry

Drug Development

Top articles of Vitaliy Sviripa

Title

Journal

Author(s)

Publication Date

Substituted N-Benzhydrylacetamide Inhibitors of Jamanji Domain Histone Demethylases for the Treatment of Cancer

2023/4/6

Crizotinib induces Par-4 secretion from normal cells and GRP78 expression on the cancer cell surface for selective tumor growth inhibition

American Journal of Cancer Research

Ravshan Burikhanov

Saptadwipa Ganguly

Sally Ellingson

Vitaliy M Sviripa

Nathalia Araujo

...

2023

Novel Superebastine Against Therapy Resistant Prostate Cancer

2022/12/8

Coumarin-modified androgens for the treatment of prostate cancer

2022/7/14

Amino-substituted 3-Aryl-and 3-heteroarylquinolines as potential antileishmanial agents

Journal of Medicinal Chemistry

Jared T Hammill

Vitaliy M Sviripa

Liliia M Kril

Diana Ortiz

Corinne M Fargo

...

2021/8/6

Chemoselective synthesis of 3-trifluoromethylpyrazole-deoxybenzoin hybrids

Journal of Fluorine Chemistry

Iryna M Biletska

Galyna P Mrug

Svitlana P Bondarenko

Kostyantyn M Kondratyuk

Yaroslav O Prostota

...

2021/2/1

Developing Quinoline-based Secretagogues for Prostate Apoptosis Response-4 Protein (Par-4) as Potential Antineoplastic Agents

Tumor Suppressor Par-4: Role in Cancer and Other Diseases

Vitaliy M Sviripa

Ravshan Burikhanov

Chunming Liu

David S Watt

2021

Potent Synergistic Effect on C-Myc–Driven Colorectal Cancers Using a Novel Indole-Substituted Quinoline with a Plk1 Inhibitor

Molecular cancer therapeutics

Yanqi Xie

Wen Zhang

Lichao Guo

Liliia M Kril

Kristin L Begley

...

2021/10/1

Pictet–Spengler condensations using 4-(2-aminoethyl) coumarins

New Journal of Chemistry

Vitaliy M Sviripa

Michael V Fiandalo

Kristin L Begley

Przemyslaw Wyrebek

Liliia M Kril

...

2020

Epigenetic regulation of Wnt signaling by carboxamide-substituted benzhydryl amines that function as histone demethylase inhibitors

Iscience

Wen Zhang

Vitaliy M Sviripa

Yanqi Xie

Tianxin Yu

Meghan G Haney

...

2020/12/18

One-Pot Access to 2-Aryl-3-(Arylmethyl) Chromones

Synthesis

Meng-Yang Chang

Kuan-Ting Chen

Yu-Lin Tsai

Han-Yu Chen

2020/3

See List of Professors in Vitaliy Sviripa University(University of Kentucky)

Co-Authors

H-index: 99
B. Mark Evers

B. Mark Evers

University of Kentucky

H-index: 8
Liliia Kril

Liliia Kril

University of Kentucky

academic-engine